{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10747",
      "entity_text" : "CD28",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P18621",
      "entity_text" : "PD-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The PD-1 ability to inhibit the initiation of both the TCR and CD28 signaling pathways explains the pleiotropic functional outcomes that result from its engagement and accounts for the ability of PD-1 to suppress TILs directed against non hematopoietic tumor cells that express ligands of PD-1 but not those of CD28.",
  "reading_complete" : "2020-08-08T15:08:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:02:10Z",
  "trigger" : "inhibit",
  "evidence" : [ "PD-1 ability to inhibit the initiation of both the TCR and CD28" ],
  "pmc_id" : "6581740",
  "score" : 0
}